Feliflea 400 mg spot-on oplossing voor extra grote honden
Feliflea 400 mg spot-on oplossing voor extra grote honden
Authorised
- Imidacloprid
Product identification
Medicine name:
Feliflea 400 mg spot-on oplossing voor extra grote honden
Active substance:
- Imidacloprid
Target species:
-
Dog
Route of administration:
-
Spot-on use
Product details
Active substance and strength:
-
Imidacloprid400.00/milligram(s)4.00millilitre(s)
Pharmaceutical form:
-
Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX17
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Netherlands
Package description:
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
- Available only in Dutch
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- C&H Generics Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
- Realoch Pharma Limited
Responsible authority:
- Medicines Evaluation Board
Authorisation number:
- REG NL 127509
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Dutch (PDF)
Published on: 10/02/2022